Becampanel (AMP 397) (Synonyms: AMP 397) |
Catalog No.GC33723 |
Becampanel (AMP 397) (AMP397) is the first competitive AMPA antagonist and an antiepileptic agent.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 188696-80-2
Sample solution is provided at 25 µL, 10mM.
Becampanel (AMP397) is the first competitive AMPA antagonist and an antiepileptic agent.
Becampanel is negative in a mouse lymphoma tk assay, which includes a 24 h treatment without S9. A weak micronucleus induction in vitro is found at the highest concentrations tested in V79 cells with S9[1].
Becampanel is negative in the following in vivo studies, which includes the maximum tolerated doses of 320 mg/kg in mice and 2000 mg/kg in rats. Becampanel has no genotoxic potential in vivo[1].
[1]. Suter W, et al. Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound. Mutat Res. 2002 Jul 25;518(2):181-94.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *